In cancers, core fucosylation of EGFR is associated with increased dimerization and phosphorylation, which leads to an increase in EGFR-mediated signaling related to tumor cell growth and malignancy (Zhang et al., 2020; Ament et al., 2023). This evidence concerns the gene EGFR and cancer.